Phase 2 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who are currently admitted to the Clinical Hospital of the Catholic University with a heart condition involving chest pain and elevated blood markers of heart damage (with or without changes on a heart tracing test)
- People who are scheduled to have a procedure to look at the arteries of the heart (coronary angiography), with a planned procedure to open any blockages, during the same hospital stay
- People who are willing and able to sign a written consent form agreeing to take part
Who may not be able to join:
- People having a major type of heart attack (called an ST-elevation myocardial infarction) that requires emergency treatment immediately, as there would not be enough time for the study medication to work
- People with a severe narrowing of the main artery supplying the heart (left main stenosis)
- People with advanced heart failure where the heart is pumping at less than 35% of its normal capacity
- People who have had a previous reaction or intolerance to the study drug colchicine, or who are already taking it for another condition such as gout
- People with severe liver disease or abnormal liver test results above a certain level
- People with certain blood count abnormalities (low white blood cell or platelet counts)
- People with significantly reduced kidney function
- People taking certain medications that interact with colchicine (including CYP3A4 inhibitors or calcineurin inhibitors)
- People with an active autoimmune disease or who regularly take anti-inflammatory medications
- People with an active infection at the time of the trial
- People who are pregnant or breastfeeding
- People with any other illness that limits life expectancy to less than one year
- People with a medical history of a condition that the treating doctor believes would put them at significant risk if they joined the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gonzalo Martínez, MD, Pontificia Universidad Catolica de Chile
Phone: 56 223543218
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Index of Microcirculatory resistance (IMR) between pre and post-coronary angioplasty.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.